This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Mesenchymal Stromal Cell Therapy in Renal Recipien...
Clinical trial

Mesenchymal Stromal Cell Therapy in Renal Recipients (MSCs)

Read time: 1 mins
Last updated:5th Feb 2014

This study will test the hypothesis that MSCs in combination with Everolimus facilitate Tacrolimus withdrawal, reduce fibrosis and decrease the incidence of opportunistic infections compared to standard tacrolimus dose.

Category Value
Study start date 2014-02-05

View full details